Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NINTEDANIB vs NIRAPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NINTEDANIB vs NIRAPARIB: Safety Overview

Metric NINTEDANIB NIRAPARIB
Total FAERS Reports 26,243 21,634
Deaths Reported 5,822 1,370
Death Rate 22.2% 6.3%
Hospitalizations 9,433 4,892
Average Patient Age 70.7 yrs 65.7 yrs
% Female Patients 41.8% 98.5%
FDA Approval Date N/A Apr 26, 2023
Manufacturer N/A GlaxoSmithKline LLC
Route N/A ORAL
Marketing Status None Discontinued